Detection and prevention of drug-drug interactions in the hospitalized elderly: Utility of new cytochrome P450-based software

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 6, 2011, Pages 461-470

  Zakrzewski Jakubiak, Hubert ^a   Doan, Julie ^a   Lamoureux, Pamela ^a   Singh, Dharmender ^a   Turgeon, Jacques ^a,c   Tannenbaum, Cara ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE DE RECHERCHE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cytochrome; drugdrug interactions; hospitalized elderly; software

Indexed keywords

AMIODARONE; AMITRIPTYLINE; AMLODIPINE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DIMENHYDRINATE; DOMPERIDONE; DONEPEZIL; FINASTERIDE; HALOPERIDOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METOPROLOL; NEUROLEPTIC AGENT; PREDNISONE; REPAGLINIDE; ROSUVASTATIN; SEROTONIN UPTAKE INHIBITOR; TAMSULOSIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGED; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER PROGRAM; CONSENSUS DEVELOPMENT; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DRUG INTERACTION; DRUG POTENTIATION; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; LABORATORY TEST; MALE; PHARMACIST; POLYPHARMACY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CLINICAL PHARMACY INFORMATION SYSTEMS; CONSENSUS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; POLYPHARMACY; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; SOFTWARE;

EID: 83555174443     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.09.006     Document Type: Article

References (15)

1. D.N. Juurlink, M. Mamdani, A. Kopp Drug-drug interactions among elderly patients hospitalized for drug toxicity JAMA 289 2003 1652 1658 (Pubitemid 37430270)
2. J. Doucet, P. Chassagne, C. Trivalle Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients J Am Geriatr Soc 44 1996 944 948 (Pubitemid 26287151)
3. K. Johnell, I. Klarin The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register Drug Saf 30 2007 911 918 (Pubitemid 47481446)
4. S.I. Haider, K. Johnell, M. Thorslund, J. Fastbom Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 19922002 Int J Clin Pharmacol Ther 45 2007 643 653 (Pubitemid 350268038)
5. B. Hovstadius, K. Hovstadius, B. Astrand, G. Petersson Increasing polypharmacy-an individual-based study of the Swedish population 20052008 BMC Clin Pharmacol 10 2010 16
6. Q. Gu, C.F. Dillon, V.L. Burt Prescription drug use continues to increase: U.S. prescription drug data for 20072008 NCHS Data Brief 2010 1 8
7. L. Mallet, A. Spinewine, A. Huang The challenge of managing drug interactions in elderly people Lancet 370 2007 185 191 (Pubitemid 47042897)
8. I.K. Bjorkman, J. Fastbom, I.K. Schmidt, C.B. Bernsten Drug-drug interactions in the elderly Ann Pharmacother 36 2002 1675 1681 (Pubitemid 35265600)
9. S.J. Davies, S. Eayrs, P. Pratt, M.S. Lennard Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards Br J Clin Pharmacol 57 2004 464 472 (Pubitemid 38519652)
10. T. Shimada, H. Yamazaki, M. Mimura Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J Pharmacol Exp Ther 270 1994 414 423 (Pubitemid 24229655)
11. S.F. Zhou Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II Clin Pharmacokinet 48 2009 761 804
12. US Food and Drug Administration. Center for Drug Evaluation and Research Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug ProductsGeneral Considerations http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070124.pdf Accessed June 8, 2011
13. European Medicines Agency. Committee for medicinal products for human use Guideline on the investigation of bioequivalence http://www.ema.europa.eu/docs/ en-GB/document-library/Scientific-guideline/2010/01/WC500070039.pdf Accessed June 8, 2011
14. D.J. Birkett Generics - equal or not? Aust Prescriber 26 2003 85 87 (Pubitemid 36934873)
15. J.L. Fleiss, B. Levin, M. Cho Paik Statistical Methods for Rates and Proportions 3rd ed. 2003 John Wiley & Sons New York, NY